These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9893924)

  • 1. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
    D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
    Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective block of N-methyl-D-aspartic acid (NMDA)-evoked whole-cell currents in mouse cultured spinal neurones by CGP 40116.
    D'Hooge R; Raes A; Van Bogaert PP; Geelhand M; De Deyn PP
    Br J Pharmacol; 1997 Jan; 120(2):211-4. PubMed ID: 9117111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
    D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP
    Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
    Chapman AG; Graham JL; Patel S; Meldrum BS
    Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral administration of the competitive N-methyl-D-aspartate antagonist, CGP 40116, on passive avoidance, spatial learning, and neuromotor abilities in mice.
    Hauben U; D'Hooge R; Soetens E; De Deyn PP
    Brain Res Bull; 1999 Feb; 48(3):333-41. PubMed ID: 10229343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on ischemic brain damage induced by four-vessel occlusion in rats.
    Okada M; Fujimura Y; Ueda H; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 Feb; 47(2):115-9. PubMed ID: 9079228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia.
    Jóźwiak L; Łukawski K; Czuczwar SJ; Sieklucka-Dziuba M
    Pol J Pharmacol; 2004; 56(1):59-66. PubMed ID: 15047978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia.
    Okada M; Ueda H; Kometani M; Nakao K; Kohjimoto Y; Takahashi I; Tanaka I
    Arzneimittelforschung; 1997 Jun; 47(6):700-2. PubMed ID: 9239445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of NMDA receptor agonist and antagonist on morphine state-dependent memory of passive avoidance in mice.
    Jafari-Sabet M; Zarrindast MR; Rezayat M; Rezayof A; Djahanguiri B
    Life Sci; 2005 Nov; 78(2):157-63. PubMed ID: 16137707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination.
    Carter AJ
    J Pharmacol Exp Ther; 1994 May; 269(2):573-80. PubMed ID: 7514220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
    Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
    De Sarro G; De Sarro A; Ammendola D; Patel S
    Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
    Okada M; Ueda H; Kometani M; Nakao K
    Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849.
    Kolasiewicz W; Maj J
    Pol J Pharmacol; 1996; 48(5):467-79. PubMed ID: 9112688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.